9-(2-Chloro-6-fluorobenzyl)-9H-purin-6-amine, 95.0%, 250mg

Bismuth hydroxide 99.9% 250 g

4'-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1'-biphenyl]-4-carbonitrile, 95.0%, 5g

1-(5-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)pyrrolidine, 97%, 1g

6-Amino-2-chloropurine, 97.0%, 100g

1-(3-Aminopropyl)imidazole, 98.0%, 10g

Diethylene glycol, min. 99%, for synthesis, 5 l, plastic packaging.

7-METHOXY-6-NITRO-1,2,3,4-TETRAHYDROISOQUINOLINE HCL, 95.0%, 100mg

3-Bromobenzaldehyde>98.0%(GC)25g

7-Bromo-2,4-dichlorothieno[3,2-d]pyrimidine, 95.0%, 1g

4-(chloromethyl)-5-methyl-2-(3-methylphenyl)-1,3-oxazole, 95.0%, 10g

Methyl 5-ethynylpyridine-2-carboxylate, 95.0%, 250mg

3-Iodo-1-(phenylsulfonyl)-1H-indole, 95.0%, 1g